retatrutide microdosing protocol tirzepatide chart: Guide to benefits, dosage and safety Mounjaro

GLP-1 medications are FDA-approved and widely studied, but like any treatment, they can have side effects

Davies M et al (2021) Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

The weight loss drug landscape is evolving at a pace most patients and even many clinicians are struggling to keep up with

The delayed gastric emptying characteristic of these medications means that food remains in the stomach longer, which can cause discomfort during exercise if meals are poorly timed

It remains restricted to regulated clinical trials